Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards Phase I SBIR to NanoInk for DNA Array Development

NEW YORK, Nov. 18 (GenomeWeb News) - NanoInk has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to support the development of its Dip Pen Nanolithography technology for miniaturizing DNA arrays, the company said today.

NanoInk said the grant is the first award of a two-phase $1.3 million award. Phase I SBIR's are generally in the $100,000 range.

The company said the grant is a result of an NIH initiative to facilitate multidisciplinary work in nanotechnology. The DPN process is able to precisely position molecules on a surface, which permits direct-deposition printing of features with nanometer-scale dimensions, according to NanoInk.

The company said it can use the technique to create biomolecule nanoarrays with features that are up to 10,000 times smaller than those produced with conventional microarray technology.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.